Published in Retina on May 30, 1984
Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study. Br J Ophthalmol (2000) 1.02
Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin inhibits the proliferation of ARPE-19 cells. J Biomed Sci (2010) 0.85
Cytotoxic effects of antiproliferative agents on human retinal glial cells in vitro. Int Ophthalmol (2001) 0.77
Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology (1997) 2.94
A novel scenario for the evolution of haem-copper oxygen reductases. Biochim Biophys Acta (2001) 2.51
Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11. Arch Ophthalmol (1997) 2.42
Birdshot retinochoroidopathy. Am J Ophthalmol (1980) 2.29
The effects of silicone oil removal. Silicone Study Report 6. Arch Ophthalmol (1994) 2.05
Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost (2010) 2.02
The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest Ophthalmol Vis Sci (1986) 1.90
Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol (1985) 1.58
Further observations on the aspiration technique in cataract surgery. Am J Ophthalmol (1971) 1.51
Advanced glycation end products in age-related macular degeneration. Arch Ophthalmol (1998) 1.51
Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated transfer of suicide gene. Can proliferative vitreoretinopathy be a target of gene therapy? Ophthalmology (1995) 1.50
Surgery of congenital cataract. Am J Ophthalmol (1965) 1.48
Subretinal neovascularization in the rat induced by IRBP synthetic peptides. Exp Eye Res (1994) 1.48
Failure of penicillin in a newborn with congenital syphilis. JAMA (1970) 1.46
The resistance of certain tissues to invasion. II. Evidence for extractable factors in cartilage which inhibit invasion by vascularized mesenchyme. Lab Invest (1975) 1.45
Transplantation of autologous iris pigment epithelium to the subretinal space in rabbits. Transplantation (1999) 1.45
Refractive lens exchange combined with pars plana vitrectomy to correct high myopia. Eye (Lond) (2005) 1.44
Postoperative intraocular pressure abnormalities in the Silicone Study. Silicone Study Report 4. Ophthalmology (1993) 1.43
Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci (1987) 1.43
Histology of wound, vitreous, and retina in experimental posterior penetrating eye injury in the rhesus monkey. Am J Ophthalmol (1979) 1.43
Vitamin E succinate inhibits proliferation and migration of retinal pigment epithelial cells in vitro: therapeutic implication for proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol (1996) 1.43
Retinal pigment epithelium cells promote the maturation of monocytes to macrophages in vitro. Ophthalmic Res (1997) 1.42
The resistance of certain tissues to invasion. III. Cartilage extracts inhibit the growth of fibroblasts and endothelial cells in culture. Am J Pathol (1975) 1.42
Method of production and natural history of experimental posterior penetrating eye injury in the rhesus monkey. Am J Ophthalmol (1979) 1.42
Ocular trauma in an urban population. Review of 1132 cases. Ophthalmology (1990) 1.42
[Progress in somatic gene therapy of retinal degeneration in the animal model]. Ophthalmologe (2002) 1.40
Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy. Eye (Lond) (2002) 1.39
The resistance of certain tissues to invasion: penetrability of explanted tissues by vascularized mesenchyme. Am J Pathol (1973) 1.39
Prediction of visual acuity recovery in cystoid macular edema. Ophthalmic Surg (1992) 1.38
Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization. Invest Ophthalmol Vis Sci (2000) 1.37
Acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol (1972) 1.37
[Management of submacular hemorrhage by tissue plasminogen activator and SF(6) gas injection]. Ophthalmologe (1999) 1.37
Defining herbivore assemblages in the Kruger National Park: a correlative coherence approach. Oecologia (2005) 1.37
Pathogenesis of drusen in the primate. Invest Ophthalmol Vis Sci (1986) 1.33
Primary epithelial neoplasms of the lacrimal sac. Am J Ophthalmol (1973) 1.31
The development of an experimental model of subretinal neovascularization in disciform macular degeneration. Trans Am Ophthalmol Soc (1979) 1.27
Subretinal neovascularization. Natural history of an experimental model. Arch Ophthalmol (1982) 1.27
Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations. Br J Ophthalmol (1993) 1.24
Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment. Clin Microbiol Infect (2005) 1.24
Argon laser photocoagulation. Advantages and limitations. Trans Am Acad Ophthalmol Otolaryngol (1971) 1.18
Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy. Br J Ophthalmol (2001) 1.18
The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration. Mol Vis (1999) 1.18
Massive suprachoroidal hemorrhage: secondary treatment and outcome. Graefes Arch Clin Exp Ophthalmol (2000) 1.17
Proteinase inhibitor activity in connective tissues. Experientia (1974) 1.16
Experimental retinal tolerance to liquid silicone. Retina (1983) 1.16
P2X7 receptors in Müller glial cells from the human retina. J Neurosci (2000) 1.16
Anterior segment ischemia following scleral buckling in sickle cell hemoglobinopathy. Am J Ophthalmol (1971) 1.14
Chemotaxis of aortic endothelial cells in response to fibronectin. Cancer Res (1982) 1.14
Experimental posterior penetrating eye injury in the rabbit. I. Method of production and natural history. Br J Ophthalmol (1979) 1.13
Promotion of adhesion and migration of RPE cells to provisional extracellular matrices by TNF-alpha. Invest Ophthalmol Vis Sci (2000) 1.12
The pathophysiology of proliferative vitreoretinopathy in its management. Am J Ophthalmol (1985) 1.11
Formation of drusen in the human eye. Am J Ophthalmol (1986) 1.11
Management of congenital cataracts. Trans Am Acad Ophthalmol Otolaryngol (1970) 1.10
Pathogenesis of laser-induced choroidal subretinal neovascularization. Invest Ophthalmol Vis Sci (1990) 1.10
The ground substance of the arterial wall. Part 1. Extractability of glycosaminoglycans and the isolation of a proteoglycan from bovine aorta. Atherosclerosis (1975) 1.09
PINCO: personal information and confidentiality controls. Long Range Plann (1983) 1.09
Long-term course of chloroquine retinopathy after cessation of medication. Am J Ophthalmol (1979) 1.08
A new model of subretinal neovascularization in the rabbit. Invest Ophthalmol Vis Sci (1995) 1.08
Pars plana vitrectomy in ocular trauma. Am J Ophthalmol (1979) 1.08
Vessel formation by choroidal endothelial cells in vitro is modulated by retinal pigment epithelial cells. Arch Ophthalmol (1995) 1.07
The incidence of corneal abnormalities in the Silicone Study. Silicone Study Report 7. Arch Ophthalmol (1995) 1.06
The 'strict' anaerobe Desulfovibrio gigas contains a membrane-bound oxygen-reducing respiratory chain. FEBS Lett (2001) 1.06
Diffuse drusen and associated complications. Am J Ophthalmol (1985) 1.05
Relaxing retinotomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 5. The Silicone Study Group. Am J Ophthalmol (1993) 1.05
Penetrating eye injuries: a histopathological review. Br J Ophthalmol (1980) 1.04
The mouse homolog of the Wiskott-Aldrich syndrome protein (WASP) gene is highly conserved and maps near the scurfy (sf) mutation on the X chromosome. Genomics (1995) 1.03
Bilateral inflammatory pseudotumors of the ciliary body. Am J Ophthalmol (1971) 1.03
Reactive lymphoid hyperplasia. An unusual form of intraocular pseudotumor. Trans Am Acad Ophthalmol Otolaryngol (1973) 1.02
Retinal wound healing. Cellular activity at the vitreoretinal interface. Arch Ophthalmol (1986) 1.02
Anchorage independent growth and plasminogen activator production by bovine endothelial cells. J Cell Biol (1980) 1.02
A comparison of different cellular inocula in an experimental model of massive periretinal proliferation. Am J Ophthalmol (1982) 1.01
Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place? Int Ophthalmol (1990) 1.01
Hysterical symptoms in ophthalmology. Doc Ophthalmol (1989) 1.01
Pericytes of newly formed vessels in experimental subretinal neovascularization. Arch Ophthalmol (1995) 1.01
Topographic variations in the rabbit and primate internal limiting membrane. Invest Ophthalmol Vis Sci (1984) 1.00
Results and complications of 100 consecutive cases of pars plana vitrectomy. Am J Ophthalmol (1975) 0.99
Differential permeance of retina and retinal pigment epithelium to water: implications for retinal adhesion. Int Ophthalmol (1993) 0.99
Morphologic observations on experimental subretinal neovascularization in the monkey. Invest Ophthalmol Vis Sci (1987) 0.98
Immunochemical studies of epiretinal membranes using APAAP complexes: evidence for macrophage involvement in traumatic proliferative vitreoretinopathy. Int Ophthalmol (1988) 0.98
Mortality prediction in cardiac surgery patients: comparative performance of Parsonnet and general severity systems. Circulation (1999) 0.98
Organization of extracellular matrix in epiphyseal growth plate. Am J Pathol (1971) 0.97
Combined posterior contusion and penetrating injury in the pig eye. II. Histological features. Br J Ophthalmol (1982) 0.97
Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2001) 0.97
Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 3. Retina (1993) 0.95
Electrophysiology of rabbit Müller (glial) cells in experimental retinal detachment and PVR. Invest Ophthalmol Vis Sci (2001) 0.94
Ocular manifestations of dwarfism. Trans Am Acad Ophthalmol Otolaryngol (1973) 0.94
Retinal pigment epithelial cells secrete and respond to hepatocyte growth factor. Biochem Biophys Res Commun (1998) 0.94
Congenital central corneal leukoma (Peters' anomaly). Am J Ophthalmol (1976) 0.93
Dexamethasone induced proliferation of cultured retinal pigment epithelial cells. Curr Eye Res (1994) 0.93
Cellular response in subretinal neovascularization induced by bFGF-impregnated microspheres. Invest Ophthalmol Vis Sci (1999) 0.93
VEGF release by retinal glia depends on both oxygen and glucose supply. Neuroreport (2000) 0.93
Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells. Invest Ophthalmol Vis Sci (1995) 0.93
Mitogen-activated protein kinase activation mediates PDGF-directed migration of RPE cells. Exp Cell Res (1998) 0.93
Experimental retinal detachment causes widespread and multilayered degeneration in rabbit retina. J Neurocytol (2001) 0.93
Retinal microglia: a new cell in idiopathic proliferative vitreoretinopathy? Exp Eye Res (1991) 0.92